CME Group Inc. $CME Stock Acquired by Boston Trust Walden Corp

Boston Trust Walden Corp lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 79.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,142 shares of the financial services provider’s stock after purchasing an additional 13,791 shares during the period. Boston Trust Walden Corp’s holdings in CME Group were worth $8,159,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CME. Covestor Ltd grew its holdings in shares of CME Group by 52.8% during the 3rd quarter. Covestor Ltd now owns 605 shares of the financial services provider’s stock worth $159,000 after acquiring an additional 209 shares during the period. Compass Financial Management LLC raised its position in shares of CME Group by 471.4% in the 3rd quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 99 shares in the last quarter. Rakuten Investment Management Inc. lifted its stake in shares of CME Group by 9.2% in the 3rd quarter. Rakuten Investment Management Inc. now owns 64,720 shares of the financial services provider’s stock valued at $17,036,000 after purchasing an additional 5,427 shares during the period. AIA Group Ltd purchased a new position in shares of CME Group in the 3rd quarter valued at approximately $4,404,000. Finally, Third View Private Wealth LLC lifted its stake in shares of CME Group by 43.8% in the 3rd quarter. Third View Private Wealth LLC now owns 1,432 shares of the financial services provider’s stock valued at $375,000 after purchasing an additional 436 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Down 0.3%

CME stock opened at $307.24 on Friday. The business has a 50 day moving average of $282.60 and a 200 day moving average of $280.66. The firm has a market cap of $109.97 billion, a PE ratio of 25.39, a price-to-earnings-growth ratio of 3.76 and a beta of 0.15. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. During the same period in the previous year, the company posted $2.68 earnings per share. The company’s revenue for the quarter was up 10.6% compared to the same quarter last year. On average, research analysts forecast that CME Group Inc. will post 12.34 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s payout ratio is currently 42.66%.

Insider Transactions at CME Group

In related news, Director Elizabeth A. Cook sold 500 shares of the stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the sale, the director directly owned 17,916 shares of the company’s stock, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Sunil Cutinho sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the completion of the transaction, the insider owned 20,037 shares of the company’s stock, valued at approximately $5,985,051.90. The trade was a 19.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,979 shares of company stock worth $9,552,762 over the last quarter. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $286.00 to $270.00 in a report on Wednesday, August 19th. Wells Fargo & Company upped their target price on shares of CME Group from $315.00 to $333.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. UBS Group increased their price target on shares of CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a research note on Thursday, October 22nd. Barclays lifted their price target on shares of CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a research report on Thursday, October 22nd. Finally, Weiss Ratings raised shares of CME Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, October 23rd. Ten investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $314.44.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.